Federal Register Notice: FDA’s Cellular, Tissue and Gene Therapies Advisory Committee will meet 11/17 from 8:30 a.m. to 5 p.m. at Hilton Washington, DC/Silver Spring, 8727 Colesville Rd., Silver Spring, MD. The committee will discuss an Organogenesis, Inc. BLA for Apligraf (oral) for treating surgically created gingival and alveolar mucosal surface defects in adults. The meeting will also be available by Web cast at http://fda.yorkcast.com/webcast/Viewer/?peid=041ef376b14f4599be568b1b2893e85d1d

Contact Gail Dapolito or Sheryl Clark, (301) 827-0314. To view this notice, click here.